Stockscreener 앱 받기
0.785
4.62%
-0.038
시장 영업 전:
.78
-0.005
-0.64%
전일 마감가:
$0.823
열려 있는:
$0.8
하루 거래량:
130.80K
Relative Volume:
0.04
시가총액:
$14.69M
수익:
$54.43M
순이익/손실:
$-36.70M
주가수익비율:
-0.2676
EPS:
-2.9334
순현금흐름:
$-19.17M
1주 성능:
+10.94%
1개월 성능:
+10.13%
6개월 성능:
-30.53%
1년 성능:
+3.29%
1일 변동 폭
$0.7835
$0.8538
1주일 범위
$0.703
$0.9622
52주 변동 폭
$0.48
$3.44
Trinity Biotech Plc Adr Stock (TRIB) Company Profile
Compare TRIB vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TRIB
Trinity Biotech Plc Adr
|
0.785 | 15.40M | 54.43M | -36.70M | -19.17M | -2.9334 |
|
ABT
Abbott Laboratories
|
111.47 | 197.52B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
365.85 | 139.09B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
100.88 | 129.59B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 108.96B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 46.04B | 6.07B | 1.06B | 799.60M | 1.8527 |
Trinity Biotech Plc Adr Stock (TRIB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2015-10-23 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2015-09-03 | 개시 | Raymond James | Outperform |
| 2015-07-29 | 재확인 | ROTH Capital | Buy |
| 2008-07-22 | 재확인 | Roth Capital | Buy |
| 2008-03-17 | 재확인 | Roth Capital | Buy |
| 2007-12-10 | 재확인 | Roth Capital | Buy |
| 2007-10-26 | 재확인 | Roth Capital | Buy |
모두보기
Trinity Biotech Plc Adr 주식(TRIB)의 최신 뉴스
Trinity Biotech receives final approval for HIV test manufacturing shift By Investing.com - Investing.com South Africa
Trinity Biotech’s HbA1c analyzer achieves IFCC gold classification By Investing.com - Investing.com South Africa
Trinity Biotech receives final approval for HIV test manufacturing shift - Investing.com
Trinity Biotech’s HbA1c analyzer achieves IFCC gold classification - Investing.com
Trinity Biotech plc (TRIB) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
Trinity Biotech plc's (NASDAQ:TRIB) Share Price Boosted 54% But Its Business Prospects Need A Lift Too - Sahm
Indaptus Therapeutics, Uipath, Trinity Biotech, Sable Offshore And McDonald's: Why These 5 Stocks Are On Investors' Radars Today - Sahm
Dow Gains 100 Points; US Durable Goods Orders Decline In October - Benzinga
TRIB: Revenue declined and losses narrowed in Q2 2025 amid restructuring and funding uncertainty - TradingView — Track All Markets
TRIB: Gross margin rose to 45.2% and Adjusted EBITDA turned positive despite a $5.1m net loss - TradingView — Track All Markets
Trinity Biotech secures $5 million funding, extends credit agreement - Investing.com India
Trinity Biotech stock soars after major HIV test order signals market recovery By Investing.com - Investing.com South Africa
Trinity Biotech stock soars after major HIV test order signals market recovery - Investing.com
Trinity Biotech secures $5 million funding, extends credit agreement By Investing.com - Investing.com South Africa
Trinity Biotech receives 9 million unit order for HIV screening product - Investing.com
Trinity Biotech receives 9 million unit order for HIV screening product By Investing.com - Investing.com South Africa
Trinity Biotech stock rises on expanded rollout of next-gen HbA1c system - Investing.com
Trinity Biotech stock rises on expanded rollout of next-gen HbA1c system By Investing.com - Investing.com South Africa
Trinity Biotech expands rollout of next-gen HbA1c testing system - Investing.com
Trinity Biotech plc (TRIB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Trinity Biotech receives WHO approval for outsourced HIV test manufacturing - Investing.com
Trinity Biotech Announces Collaboration to Advance Epigenetic Analysis for EpiCapture Prostate Cancer Test - GlobeNewswire Inc.
Why You Need Trinity Biotech Plc ADR (TRIB) On Your Watchlist - fostersleader.com
Operating cash flow per share of Trinity Biotech Plc Sponsored ADR Class A – LS:A404JF - TradingView
EBIT per share of Trinity Biotech plc ADR – MUN:TRB0 - TradingView
Top investors say Banco Macro S.A. ADR (BMA) ticks everything they need - Setenews
Trinity Biotech : 2025 AGM Notice Sent to holders of Ordinary Shares - MarketScreener
TRINITY B ADR : Trinity Biotech plc to Present at Sidoti & Company's Micro-Cap Conference on January 10, 2011 - MarketScreener
Upcoming Stock Splits This Week (August 25 to August 29) – Stay Invested - TipRanks
Trinity Biotech plc Appoints Paul Tivnan as Non-Executive Director - MarketScreener
Trinity Biotech appoints Paul Tivnan to board of directors - Investing.com
Trinity Biotech receives approval for offshore manufacturing of HIV test - Investing.com
TRIB’s Market Quandary: Decoding the Ups and Downs of 2025 - investchronicle.com
Trinity Biotech stock soars after NY regulatory approval for preeclampsia test By Investing.com - Investing.com South Africa
Trinity Biotech stock soars after NY regulatory approval for preeclampsia test - Investing.com India
Trinity Biotech receives NY approval for preeclampsia test - Investing.com
Trinity Biotech stock rises on successful CGM calibration-free trial By Investing.com - Investing.com South Africa
Trinity Biotech stock rises on successful CGM calibration-free trial - Investing.com India
Trinity Biotech reports positive results for calibration-free CGM By Investing.com - Investing.com South Africa
Trinity Biotech reports positive results for calibration-free CGM - Investing.com India
Trinity Biotech (TRIB) to Release Earnings on Wednesday - Defense World
Trinity Biotech launches preeclampsia testing service for maternal health By Investing.com - Investing.com South Africa
Trinity Biotech launches preeclampsia testing service for maternal health - Investing.com
Trinity Biotech Plc Sponsored ADR Class A to Host Earnings Call - ACCESS Newswire
Trinity Biotech Unveils CGM+: An AI-Native Platform Targeting the $260 Billion AI Wearable Market - Sahm
Trinity Biotech Reaches Profitability Inflection Point, Marking Major Milestone in Strategic Turnaround - MarketScreener
Trinity Biotech Secures Key Regulatory Approval for Offshored and Outsourced Manufacturing of Its Flagship Rapid HIV Test, Accelerating Strategic and Financial Performance Transformation - MarketScreener
Trinity Biotech receives WHO approval for offshore HIV test manufacturing - Investing.com
Trinity Biotech Appoints New Interim CFO - Investing.com
Trinity Biotech Further Strengthens Focus on Continuous Glucose Monitoring – Appoints Barclays to Advise on Ongoing Strategic Realignment Process - MarketScreener
Trinity Biotech stock hits 52-week low at $0.72 amid challenges - Investing.com
Trinity Biotech Plc Adr (TRIB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.45%
0.31%
자본화:
|
볼륨(24시간):